Discoveries made when biology meets computational sciences are revolutionising the landscape of life sciences and healthcare. Computational biology and bioinformatics are driving this transformation helping researchers analyse vast amounts of ...
Read MoreSMITHS FALLS, ON , June 24, 2017 /CNW/ - Earlier this week, Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") provided a global operational update to keep shareholders and other stakeholders apprised of operational ...
Read MoreMADRID , June 24, 2017 /PRNewswire/ -- Providing the right treatment in time for patients with hematologic malignancies: that is the ambition of the HARMONY Alliance , European Network of Excellence in Hematology and Big Data. HARMONY ...
Read MoreMADRID , June 24, 2017 /PRNewswire/ -- Ibrutinib: A promising n ew t reatment for c hronic g raft v ersus h ost d isease . Chronic graft versus host disease (cGVHD) is a serious and life-threatening complication ...
Read MoreMADRID , June 24, 2017 /PRNewswire/ -- CTL019 consists of genetically engineered autologous T cells expressing a chimeric antigen receptor (CAR). Results from a prior single-center phase 2 study at the University of Pennsylvania showed that ...
Read MoreMADRID , June 24, 2017 /PRNewswire/ -- The risk of blood clots in the veins of the legs or the lungs, known as venous thrombosis (VTE) is higher in cancer patients, and so is the risk of bleeding. Whereas anticoagulant therapy lowers the risk ...
Read MoreMADRID , June 24, 2017 /PRNewswire/ -- Hodgkin lymphoma is the most common malignancy of young adults. Intensive chemotherapy with eight or six cycles of eBEACOPP is very effective in patients with advanced-stage Hodgkin's lymphoma (HL), ...
Read MoreMADRID , June 24, 2017 /PRNewswire/ -- Outcomes for patients with refractory, aggressive non-Hodgkin lymphoma (NHL) are poor with current therapies. Axicabtagene ciloleucel (axi-cel) is an anti-CD19 chimeric antigen receptor (CAR) T cell ...
Read MoreNEW YORK , June 23, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP). Such investors are advised to contact Robert S. Willoughby at ...
Read MoreResearchers from Ram Group's Israeli team developed a breakthrough in molecular diagnostic sensors detecting cancer early before metastasis SINGAPORE , June 23, 2017 /PRNewswire/ -- Researchers at Ram Group's Israeli bio-sensor division ...
Read MoreSACRAMENTO, Calif. , June 23, 2017 /PRNewswire/ -- Six Sutter Medical Network (SMN) physician organizations that participated in the 2017 Standards of Excellence TM (SOE ® ) member survey , including all five medical foundations, earned Elite ...
Read MoreBOSTON , June 23, 2017 /PRNewswire/ -- Simon Gelman, M.D., Ph.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical Education field. Dr. Gelman serves as a Distinguished Professor of ...
Read MoreLAS VEGAS , June 23, 2017 /PRNewswire/ -- Gregory P. Brown , M.D., is recognized by Continental Who's Who for Excellence in Psychiatry and Forensic Psychiatry. Dr. Brown serves as a Psychiatrist at the University of Nevada ...
Read MoreDYER, Ind. , June 23, 2017 /PRNewswire/ -- Diana Goodwin, R.N., B.S.N., is recognized for Excellence in Nursing by Continental Who's Who as a Pinnacle Professional Member in the field of Healthcare. Goodwin serves as the Director of Nursing ...
Read MorePHILADELPHIA , June 23, 2017 /PRNewswire/ -- FMC Corporation (NYSE: FMC) has signed a definitive agreement to sell its Epax® Omega-3 business to Pelagia AS. The transaction is expected to close by the end of Q3 2017, subject to customary ...
Read MoreAfrican Americans and Latinas Saw Largest Increases in Stage 1 Diagnoses MAYWOOD, Ill. , June 23, 2017 /PRNewswire-USNewswire/ -- A Loyola University Chicago study published this month has found an increase in the percentage of ...
Read MoreCHARLOTTE, N.C. , June 23, 2017 /PRNewswire/ -- Therap Services, the leader in electronic documentation software for Intellectual and Developmental Disability service providers, announces successful implementation of its I/DD software at ...
Read MoreCHAPEL HILL, N.C. , June 23, 2017 /PRNewswire/ -- New cancer therapies continue to make their way through the development and approval process in the United States as part of the oncology therapeutic area's resurgence. But the variety of ...
Read MoreSubscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers